Announcements Trials
Browse Landscape

Status

Recruiting 22Active not recruiting 6Terminated 2Not yet recruiting 2Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 51Neoplasms 45Colorectal Neoplasms 27Carcinoma, Non-Small-Cell Lung 22Prostatic Neoplasms 20Lung Neoplasms 16Leukemia, Myeloid, Acute 16Recurrence 12Multiple Myeloma 11Melanoma 11Stomach Neoplasms 10Head and Neck Neoplasms 10Ovarian Neoplasms 9Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Pancreatic Neoplasms 7Neoplasm Metastasis 7Myelodysplastic Syndromes 7Lymphoma 7Glioma 7Carcinoma, Renal Cell 7Brain Neoplasms 7Motor Activity 6Leukemia 6Hodgkin Disease 6Esophageal Neoplasms 6Colonic Neoplasms 6Carcinoma, Hepatocellular 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Transitional Cell × 30 days × Clear all
NCT07386847 2026-05-28

A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer

Pfizer

Completed
1 enrolled
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡